Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers

• Sigma Additive Solutions, Inc. SASI shares jumped 196% to $7.34 after the company announced the signing of a definitive agreement for the acquisition of NextTrip Holdings, Inc.
• Bio-Path Holdings, Inc. BPTH shares climbed 102% to $0.7961 after gaining more than 6% on Thursday.
• Shift Technologies, Inc. SFT gained 60% to $0.2145, after falling around 21% on Thursday.
• C3is Inc. CISS gained 32% to $0.5625.
• Comtech Telecommunications Corp. CMTL shares climbed 30.6% to $10.63 after posting better-than-expected fourth-quarter results.
• Versus Systems Inc. VS shares climbed 29.1% to $0.4246 after jumping more than 52% on Thursday.
• Outlook Therapeutics, Inc. OTLK gained 26% to $0.3448
• SunOpta Inc. STKL gained 22.5% to $3.5050 after the company announced the sale of certain frozen fruit assets to Nature's Touch for an aggregate purchase price of $141 million and issued preliminary Q3 results.
• PSQ Holdings, Inc. PSQH climbed 22% to $5.55. The company said preliminary third quarter revenue climbed around 300% sequentially, to an estimated $2.2 million, representing 1,600% year-over-year growth.
• EHang Holdings Limited EH jumped 21% to $20.77 after the company obtained a type certificate for the EH216-S passenger-carrying UAV system issued by the Civil Aviation Administration of China.
• SELLAS Life Sciences Group, Inc. SLS gained 18% to $1.27. SELLAS Life Sciences issued an update on Phase 3 REGAL clinical trial for Galinpepimut-S in acute myeloid leukemia.
• Celularity Inc. CELU rose 17.7% to $0.3179.
• Processa Pharmaceuticals, Inc. PCSA gained 16% to $0.3826.
• Hecla Mining Company HL climbed 13.7% to $4.1650 after Roth MKM upgraded the stock from Neutral to Buy and raised its price target from $4 to $4.4.
• Viasat, Inc. VSAT climbed 13.5% to $19.06.
• Coeur Mining, Inc. CDE gained 13.2% to $2.5399.
• Groupon, Inc. GRPN jumped 13.2% to $12.38 after Roth MKM initiated coverage on the stock with a Buy rating and $30 price target.
• Synchronoss Technologies, Inc. SNCR surged 13% to $0.5426.
• Oblong, Inc. OBLG shares gained 12.1% to $0.3286.
• Blue Star Foods Corp. BSFC shares gained 10% to $0.2201.
• Staffing 360 Solutions, Inc. STAF rose 9.2% to $0.7550.
• Dollar General Corporation DG climbed 8.5% to $110.50 after the company updated financial guidance for FY23 and announced Todd Vasos has been appointed CEO.
• First Majestic Silver Corp. AG climbed 8.5% to $5.34.
• The Progressive Corporation PGR gained 7.7% to $154.27 after the company reported third-quarter results.
• RedHill Biopharma Ltd. RDHL rose 6.9% to $0.3976. RedHill Biopharma recently said that its oral opaganib shows a significant increase in survival time (at 150 mg/kg twice daily dose) in a U.S. Army-funded in vivo Ebola virus study, making it the first host-directed molecule to show activity in the Ebola virus disease.
• JPMorgan Chase & Co. JPM gained 3.6% to $151.09 as the company reported better-than-expected earnings for its third quarter on Friday.
• Wells Fargo & Company WFC gained 3.2% to $41.03 following third-quarter earnings.

Losers

• Bellerophon Therapeutics, Inc. BLPH fell 53.4% to $0.1852.
• Outset Medical, Inc. OM shares fell 47.6% to $3.55. The company announced preliminary revenue for the third quarter of $30.4 million, below the consensus estimate of $36.03 million.
• MSP Recovery, Inc. LIFW dipped 44% to $1.8109.
• SMART Global Holdings, Inc. SGH fell 40.4% to $14.04 after the company reported worse-than-expected fourth-quarter financial results and issued a weak forecast for the first quarter.
• Harmony Biosciences Holdings, Inc. HRMY declined 38.3% to $18.66 after the company reported topline data from its Phase 3 INTUNE study of pitolisant for IH, noting no statistically significant difference was observed
• between pitolisant and placebo on ESS.
• Secoo Holding Limited SECO fell 38% to $0.6327.
• FLJ Group Limited FLJ fell 31.9% to $0.2301.
• PMV Pharmaceuticals, Inc. PMVP declined 27.7% to $1.7999. PMV Pharmaceuticals recently announced updated Phase 1 results from its ongoing Phase 1/2 PYNNACLE trial that showed PC14586 achieved efficacy in heavily pretreated patients across multiple tumor types and was well tolerated with a favorable safety profile.
• LQR House Inc. LQR declined 26.6% to $0.1739 after the company announced the pricing of a $5.4 million public offering of 28,421,053 shares of common stock at a price of $0.19 per share.
• Belden Inc. BDC fell 25.7% to $70.76 after the company lowered third-quarter revenue guidance below estimates.
• Scully Royalty Ltd. SRL declined 25% to $4.1990.
• Charles & Colvard, Ltd. CTHR fell 23% to $0.44 following quarterly results.
• Cassava Sciences, Inc. SAVA fell 21.3% to $13.80 after a recent report by the City University of New York implicated a long-time collaborator of the company in scientific misconduct related to 20 research papers.
• Edesa Biotech, Inc. EDSA shares fell 21.1% to $3.8501 after jumping around 80% on Thursday. Edesa Biotech secured a commitment of up to C$23 million from the Government of Canada for a pivotal Phase 3 clinical study of the company's first-in-class therapeutic candidate.
• Prestige Wealth Inc. PWM fell 18.7% to $3.43.
• ReShape Lifesciences Inc. RSLS fell 17.9% to $0.2795, after surging over 25% on Thursday.
• Nuwellis, Inc. NUWE fell 17.8% to $0.8301. Nuwellis reported pricing of $2.25 million public offering of Series J convertible redeemable preferred stock and warrants.
• Tian Ruixiang Holdings Ltd TIRX fell 15.7% to $0.8850, after jumping 28% on Thursday.
• BeyondSpring Inc. BYSI shares fell 15.1% to $0.9089, after jumping 46% on Thursday.
• ATRenew Inc. RERE declined 13.4% to $1.8350.
• Tango Therapeutics, Inc. TNGX fell 11.5% to $6.90.
• Sterling Infrastructure, Inc. STRL fell 11.2% to $68.79.
• AMC Entertainment Holdings, Inc. AMC fell 9.9% to $9.91.
• LogicMark, Inc. LGMK shares fell 9.7% to $1.76 after jumping around 25% on Thursday.
• Society Pass Incorporated SOPA shares fell 9.7% to $0.3201. Society Pass shares jumped around 33% on Thursday after the company announced an equity line of up to $40 million to invest into operating subsidiaries projected to go public in 2024.
• Ribbon Communications Inc. RBBN declined 8.8% to $2.2050.
• Hormel Foods Corporation HRL fell 4.5% to $30.93 following the company's Thursday investor day event. Additionally, Goldman Sachs maintained a Sell rating on the stock and lowered its price target from $33 to $29.
• JD.com, Inc. JD fell 4.1% to $26.71. Macquarie downgraded JD.com from Outperform to Neutral and lowered the price target from $52 to $32, while Morgan Stanley downgraded the stock from Overweight to Equal-Weight and slashed the price target from $55 to $33.

Now Read This: Cramer Likes This Industrial Stock: A 'Well-Run' Company Doing 'A Lot Of Good Things'